Evidence map›Paper›PMID 39695723›Full record

ArticleMalaria journal2024

Effect of seasonal malaria chemoprevention on incidence of malaria among children under five years in Kotido and Moroto Districts, Uganda, 2021: time series analysis.

Andrew Kwiringira, Benon Kwesiga, Richard Migisha, Lilian Bulage, Daniel Kadobera, Damian Rutazaana, Julie R Harris, Alex R Ario, Julius Ssempiira

Abstract read
In one paragraph

Article in Malaria journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Andrew KwiringiraUganda Public Health Fellowship Programme, Kampala, Uganda. akwiringira@musph.ac.ug.
Benon KwesigaUganda Public Health Fellowship Programme, Kampala, Uganda.
Richard MigishaUganda Public Health Fellowship Programme, Kampala, Uganda.
Lilian BulageUganda Public Health Fellowship Programme, Kampala, Uganda.
Daniel KadoberaUganda Public Health Fellowship Programme, Kampala, Uganda.
Damian RutazaanaNational Malaria Control Division, Ministry of Health, Kampala, Uganda.
Julie R HarrisUS Centers for Disease Control and Prevention, Kampala, Uganda.
Alex R ArioUganda Public Health Fellowship Programme, Kampala, Uganda.
Julius SsempiiraUS Centers for Disease Control and Prevention, Kampala, Uganda.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSeasonal malaria chemoprevention (SMC) refers to monthly administration of full treatment courses of anti-malarial medicine to children <5 years during high malaria transmission seasons. SMC has demonstrated effectiveness in Sahel and sub-Sahel countries in Africa. However, it was not implemented in Uganda until April 2021, when the country began SMC in the highly malaria-endemic Kotido and Moroto Districts. This study assessed the effect of SMC on malaria incidence among children <5 years of age in Kotido and Moroto Districts.

methodsAn interrupted time-series analysis was conducted using monthly national health data from the Uganda Ministry of Health District Health Information System 2. The monthly data for outpatient (uncomplicated) malaria among children <5 years was extracted for the 52 months before SMC implementation (Jan 2017-Apr 2021) and 8 months during SMC implementation (May-Dec 2021). The monthly incidence of uncomplicated malaria per 1000 children <5 years was computed before and during SMC implementation.

resultsIn Kotido District, malaria incidence was 693/1000 during SMC implementation period, compared to an expected 1216/1000 if SMC had not been implemented. The mean monthly malaria incidence was 87/1000, compared to an expected mean of 152/1000 if SMC had not been implemented. This represents a statistically significant mean monthly change of -65.4 (95% CI = -104.6, -26.2) malaria cases/1000 during SMC implementation, or a 43.0% decline. In Moroto District, malaria incidence was 713/1000 during SMC implementation period, compared to an expected 905/1000 if SMC had not been implemented. The mean monthly malaria incidence was 89/1000, compared to an expected 113/1000 if SMC had not been deployed. This represents a statistically significant mean monthly change of -24.0 (95% CI = -41.1, -6.8) malaria cases/1000 during SMC implementation, or a 21.2% decline.

conclusionImplementation of SMC substantially reduced the incidence of uncomplicated malaria among children <5 years in Moroto and Kotido Districts. Scaling up SMC in other districts with high malaria transmission could reduce malaria on a large scale across Uganda.

Indexed as

AntimalarialsChemopreventionInterrupted Time Series AnalysisMalariaSeasonsChild, PreschoolFemaleHumansIncidenceInfantInfant, NewbornMaleUgandaAntimalarialsHigh malaria transmissionMalariaSeasonal malaria chemopreventionUganda

Identifiers

PMID39695723
PMCPMC11657844

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.